We are live on
!
Find out more
AIM
Aigen Investment Management Portfolio holdings
AUM
$389M
1-Year Est. Return
16.77%
This Fund
S&P 500
This Quarter
Est. Return
-28.09%
1 Year Est. Return
+16.77%
3 Year Est. Return
+38.84%
5 Year Est. Return
+26.96%
10 Year Est. Return
–
AUM
$753M
AUM Growth
+$149M
(+25%)
Cap. Flow
+$464M
Cap. Flow
% of AUM
61.59%
Top 10 Holdings %
Top 10 Hldgs %
9.44%
Holding
1,737
New
568
Increased
434
Reduced
241
Closed
491
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$11.5M |
| 2 |
Nucor
NUE
|
+$9.58M |
| 3 |
Microsoft
MSFT
|
+$9.57M |
| 4 |
Duke Energy
DUK
|
+$9.38M |
| 5 |
Costco
COST
|
+$7.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$10M |
| 2 |
FirstEnergy
FE
|
+$7.33M |
| 3 |
Exelon
EXC
|
+$6.32M |
| 4 |
Cincinnati Financial
CINF
|
+$6.04M |
| 5 |
Johnson Controls International
JCI
|
+$5.79M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.54% |
| 2 | Healthcare | 14.02% |
| 3 | Financials | 13.64% |
| 4 | Consumer Discretionary | 11.63% |
| 5 | Industrials | 11.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAXR
301
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $730K | 0.1% |
+68,376
| New | +$1.07M |
|
302
Karyopharm Therapeutics
KPTI
$44.4M
| $728K | 0.1% |
2,527
-686
| -21% | -$189K |
|
303
Eli Lilly
LLY
$1.1T
| $728K | 0.1% |
+5,251
| New | +$721K |
|
304
Signet Jewelers
SIG
$3.67B
| $727K | 0.1% |
112,641
+82,284
| +271% | +$1.68M |
|
|
TERP
305
DELISTED
TerraForm Power, Inc
TERP
| $727K | 0.1% |
46,105
+6,894
| +18% | +$120K |
|
306
Southern Company
SO
$105B
| $722K | 0.1% |
+13,328
| New | +$844K |
|
307
Fair Isaac
FICO
$22.7B
| $721K | 0.1% |
2,343
+2,170
| +1,254% | +$799K |
|
308
Enviri
NVRI
$615M
| $720K | 0.1% |
103,252
+100,774
| +4,067% | +$1.38M |
|
309
Assured Guaranty
AGO
$3.36B
| $719K | 0.1% |
27,873
+6,980
| +33% | +$289K |
|
310
Textron
TXT
$15.3B
| $714K | 0.09% |
+26,789
| New | +$1.08M |
|
|
TBI
311
Trueblue
TBI
$323M
| $711K | 0.09% |
55,749
+55,713
| +154,758% | +$998K |
|
312
Las Vegas Sands
LVS
$29.4B
| $710K | 0.09% |
+16,717
| New | +$1.01M |
|
313
Hyatt Hotels
H
$16B
| $707K | 0.09% |
+14,761
| New | +$1.12M |
|
314
Skyworks Solutions
SWKS
$10.4B
| $707K | 0.09% |
+7,915
| New | +$845K |
|
315
Liberty Global Class C
LBTYK
$3.41B
| $705K | 0.09% |
+44,847
| New | +$843K |
|
316
Sensient Technologies
SXT
$5.51B
| $705K | 0.09% |
+16,198
| New | +$892K |
|
317
CenterPoint Energy
CNP
$26.4B
| $700K | 0.09% |
+45,311
| New | +$1.04M |
|
318
Kroger
KR
$34.6B
| $698K | 0.09% |
+23,170
| New | +$680K |
|
319
IQVIA
IQV
$39.8B
| $695K | 0.09% |
+6,441
| New | +$920K |
|
|
NEWR
320
DELISTED
New Relic, Inc.
NEWR
| $693K | 0.09% |
14,983
-3,792
| -20% | -$221K |
|
321
Ironwood Pharmaceuticals
IRWD
$669M
| $690K | 0.09% |
68,418
-16,308
| -19% | -$192K |
|
322
OSI Systems
OSIS
$3.83B
| $689K | 0.09% |
9,996
+6,743
| +207% | +$576K |
|
|
MSGN
323
DELISTED
MSG Networks Inc.
MSGN
| $688K | 0.09% |
67,460
-41,080
| -38% | -$586K |
|
324
CBRE Group
CBRE
$41.7B
| $687K | 0.09% |
+18,208
| New | +$1.01M |
|
325
Neurocrine Biosciences
NBIX
$16.8B
| $686K | 0.09% |
7,924
-1,374
| -15% | -$134K |
|
Similar funds
SA
WCM
PFPGI
PG
SI
TCM
HBWM
DAM
Aigen Investment Management's Q1 2020 Portfolio in Review
As of Q1 2020, Aigen Investment Management held 1,737 positions worth $753M, up 25% from $604M the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Aigen Investment Management deployed $464M of net new capital in Q1 2020, opening 568 new positions and adding to 434 existing holdings. Its largest new stake was Nucor: 215,804 shares worth $7.77M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Zoetis, an estimated $10M trimmed.
- Aigen Investment Management's largest Q1 2020 buy was Nucor: 215,804 shares worth $7.77M.
- Aigen Investment Management added most to Thermo Fisher Scientific in Q1 2020, an estimated $11.5M increase.
- Aigen Investment Management's biggest Q1 2020 reduction was Zoetis, cutting an estimated $10M.
- Aigen Investment Management fully exited FirstEnergy in Q1 2020, selling an estimated $7.33M.
- Aigen Investment Management's ten largest holdings make up 9.4% of its $753M portfolio in Q1 2020.
- Aigen Investment Management opened 568 new positions and closed 491 in Q1 2020.
- Aigen Investment Management's portfolio value rose 25% quarter-over-quarter to $753M.
Based on Aigen Investment Management's 13F filing for Q1 2020, filed 8 May 2020.